SITE SUPPORTED BY VALNEVA USA, INC.
Terms of Use | Privacy Declaration | Contact Valneva | Valneva.com
1807-US-IX-044-0819 | Copyright © 2019 Valneva USA, Inc. All Rights Reserved.
SITE SUPPORTED BY VALNEVA USA, INC.
Terms of Use | Privacy Declaration | Contact Valneva | Valneva.com
1807-US-IX-044-0819 | Copyright © 2019 Valneva USA, Inc. All Rights Reserved.
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Last Updated: February 23, 2018
Please read the following terms and conditions (the “Terms of Use”) carefully before using the www.valneva.us Website and any other web pages or other online services that are owned by Valneva USA Inc. or one of its affiliated corporations (“Valneva” or “us”) and which link to or refer to these Terms of Use (collectively referred to as the “Site“).
THESE TERMS CONTAIN DISCLAIMERS OF WARRANTIES, DISCLAIMERS OF LIABILITY, AND A BINDING ARBITRATION CLAUSE AND CLASS ACTION WAIVER. PLEASE READ THEM CAREFULLY.
IF YOU ARE NOT WILLING TO ACCEPT THESE TERMS OF USE, DO NOT ACCESS OR USE THE WEBSITE OR POST OR SUBMIT ANY MATERIALS ON IT.
Your use of the Site shall be deemed to constitute your agreement to be legally bound by Terms of Use.
“Content” includes, without limitation, messages, information, data, text, software or images, or other content, articles, photographs, images, illustrations, audio clips, video clips and other materials or content available or posted on the Site (collectively, the “Content”).
1. Site Intended Audience
The Site is intended for and directed to residents of the United States. The Site is not intended for anyone under the age of 18.
2. Disclaimers
THE INFORMATION, INCLUDING ANY ADVICE AND RECOMMENDATIONS ON THE WEBSITE, IS INTENDED SOLELY AS A GENERAL EDUCATIONAL AID. IT IS NOT INTENDED AS MEDICAL OR HEALTHCARE ADVICE, OR TO BE USED FOR MEDICAL DIAGNOSIS OR TREATMENT, FOR ANY INDIVIDUAL PROBLEM. IT IS ALSO NOT INTENDED AS A SUBSTITUTE FOR PROFESSIONAL ADVICE AND SERVICES FROM A QUALIFIED HEALTHCARE PROVIDER FAMILIAR WITH YOUR UNIQUE FACTS. ALWAYS SEEK THE ADVICE OF YOUR DOCTOR OR OTHER QUALIFIED HEALTHCARE PROVIDER REGARDING ANY MEDICAL CONDITION AND BEFORE STARTING ANY NEW TREATMENT. YOUR USE OF THE WEBSITE IS SUBJECT TO THE ADDITIONAL DISCLAIMERS AND CAVEATS THAT MAY APPEAR THROUGHOUT THE WEBSITE. WE ASSUME NO RESPONSIBILITY FOR ANY CONSEQUENCE RELATING DIRECTLY OR INDIRECTLY TO ANY ACTION OR INACTION YOU TAKE BASED ON THE INFORMATION, SERVICES, OR OTHER MATERIAL ON THE WEBSITE. WHILE WE STRIVE TO KEEP THE INFORMATION ON THE WEBSITE ACCURATE, COMPLETE, AND UP-TO-DATE, WE DO NOT GIVE ANY ASSURANCES, AND WILL NOT BE RESPONSIBLE FOR, ANY DAMAGE OR LOSS RELATED TO THE ACCURACY, COMPLETENESS, OR TIMELINESS OF THE CONTENT AND INFORMATION ON THE WEBSITE.
Moreover, Valneva does not guarantee nor warrant continuous, uninterrupted or secure access to the Site or to the tools or services provided through the Site. You should be aware the operation of the Site may be interrupted with or without prior warning or notice.
Valneva makes no representations whatsoever about any other website that you may access through the Site, such as where the Site provides a link to another website. A link to a website does not mean that Valneva endorses or accepts any responsibility for the content, practices, or use of such other website.
3. Intellectual Property and Permissible Use
The Site, including without limitation all Content, is protected by U.S. and worldwide copyrights laws and treaty provisions. Any unauthorized copying, redistribution, reproduction or modification of the Content by any person may be a violation of trade-mark and/or copyright laws and could result in legal action. You agree to comply with all applicable copyright laws.
You understand that the Site and the Content are available for your personal, non-commercial use only. You agree that the Site and the Content are the property of Valneva; including all intellectual property rights in them and that you have no right to use them other than as set out in these Terms of Use. We are not responsible for any harm or loss that you suffer in relation to any use you make of the Site for any business purposes or other purposes not authorized under these Terms of Use. We reserve the right to refuse or terminate access to the Site at our discretion. The Site is provided free of charge and we have no obligation to provide any maintenance or support services in relation to them and we are not responsible for any loss or damage you may suffer as a result of any failure to maintain or update the Site.
You may not copy, change or reuse the Site, Content, any updates to them or any part of them including the software incorporated in them, except that you may make use of the Content for your own personal use as follows: you may make one machine readable copy and/or print copy that is limited to occasional articles of personal interest only.
You may use the Site only for lawful purposes and in accordance with these Terms of Use. You are granted a nonexclusive, nontransferable, revocable, limited license to view, print and distribute content retrieved from the Site for your personal, noncommercial purposes, provided that you do not remove or obscure the copyright notice or other notices displayed on the content. You may not copy, reprint, modify, display, perform, translate, distribute, adapt, broadcast, communicate to the public by telecommunication, circulate, or sell the content retrieved from the Site in any way, for any commercial use or provide it to any commercial source, including other websites, without the prior written permission of Valneva.
In addition, you agree not to: (i) use the Site in any manner that could disable, overburden, damage, or impair the Site, or interfere with any other use of the Site, including any user’s ability to engage in real-time activities through the Site; (ii) use any robot, spider or other automatic device, process or means to access the Site for any purpose, including to scrape, data mine, monitor or copy any of the material on the Site; (iii) use any manual process to monitor or copy any of the material on the Site, or to engage in any other unauthorized purpose without the express prior written consent of Valneva; (iv) otherwise use any device, software or routine that interferes with the proper working of the Site; (v) attempt to decipher, decompile, disassemble, or reverse-engineer any of the software comprising or in any way making up a part of the Site; (vi) take any action that violates or threatens our system or network security; (vi) engage in any other conduct that violates any laws; restricts or inhibits any other person from using or enjoying the Site; or otherwise interferes with the proper working of the Site or could harm us or any third party.
We reserve all rights not expressly granted to you.
Notwithstanding rights held by any third party in incorporated elements or software, the Site is an original compilation of independent works and its “look and feel”, including the Content, data, source code or other materials is protected by copyright and is owned or controlled by Valneva and any others which may own copyright or the party credited as the provider of the Content. All visitors shall abide by all copyright notices, information and restrictions contained in any Content.
Any product, process, or technology described in the Site may be subject to other intellectual property rights reserved by Valneva or any third party as the case may be. Nothing contained herein shall be construed as conferring by implication, estoppel or otherwise any license or right under any patent or trademark of Valneva or any third party. Except as provided above, nothing contained herein shall be construed as conferring any license or right under any Valneva or third party copyright.
4. Trademark Notices
The trademarks and brand names displayed on the Site are the property of Valneva, its affiliates or third party owners. You may not use or display any such trademarks or service marks without our prior written consent. You may not use or display any other trademarks or service marks displayed on the Site without the permission of their owners.
5. Electronic Communications
The information communicated on the Site constitutes an electronic communication. When you communicate with us through the Site or via other forms of electronic media, such as e-mail, you are communicating with us electronically. You agree that we may communicate electronically, consistent with applicable law, and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.
6. Additional Terms
Additional terms may govern certain features or content on the Site, such as offers, prize draws, competitions, contests and sweepstakes. By participating in any activity on the Site governed by additional terms, such as a prize draw, competition, contest or sweepstakes with Official Rules, you agree that you will be subject to those additional terms in addition to these Terms of Use.
7. Disclaimer of Warranties With Respect to Use of Site
THE SITE IS PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS. EXCEPT AS SPECIFICALLY PROVIDED HEREIN, TO THE FULLEST EXTENT PERMISSIBLE PURSUANT TO APPLICABLE LAW, WE EXPRESSLY DISCLAIM ALL WARRANTIES OF ANY KIND, WHETHER EXPRESS, LEGAL OR IMPLIED, INCLUDING, WITHOUT LIMITATION, ANY WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NON-INFRINGEMENT.
WE DO NOT MAKE ANY WARRANTY THAT THE SITE WILL MEET YOUR REQUIREMENTS, OR THAT ACCESS TO THESITE WILL BE UNINTERRUPTED, TIMELY, SECURE, OR ERROR-FREE, OR THAT DEFECTS, IF ANY, WILL BE CORRECTED. WE MAKE NO WARRANTIES AS TO THE RESULTS THAT MAY BE OBTAINED FROM THE USE OF THE WEBSITE OR AS TO THE ACCURACY, QUALITY, OR RELIABILITY OF ANY INFORMATION OBTAINED THROUGH THE SITE.
YOU UNDERSTAND AND AGREE THAT ANY MATERIAL AND/OR DATA DOWNLOADED OR OTHERWISE OBTAINED THROUGH THE USE OF THE SITE IS USED AT YOUR OWN RISK AND THAT YOU WILL BE SOLELY RESPONSIBLE FOR ANY DAMAGE TO YOUR COMPUTER SYSTEM OR LOSS OF DATA THAT RESULTS FROM THE DOWNLOAD OF SUCH MATERIAL AND/OR DATA. NO ADVICE OR INFORMATION, WHETHER ORAL OR WRITTEN, OBTAINED BY YOU FROM VALNEVA OR THROUGH THE WEBSITE SHALL CREATE ANY WARRANTY NOT EXPRESSLY MADE HEREIN.
8. Applicable Law and Jurisdiction; Arbitration; Class Action Waiver
The information on the Site is intended only for use by residents of the United States. Other countries may have laws, regulatory requirements, or medical practices that differ from those in United States.
With respect to any and all disputes arising out of or relating to the Site or these Terms of Use (including without limitation the Privacy Policy), Valneva and you agree to negotiate in good faith and undertake reasonable efforts to cooperate with one another in order to achieve a mutually satisfactory resolution. If you and the Valneva do not resolve any dispute by informal negotiation, any other effort to resolve the dispute will be conducted exclusively by binding arbitration as described in this section. You are giving up the right to litigate (or participate in as a party or class member) all disputes in court before a judge or jury. Instead, all disputes will be resolved before a neutral arbitrator, whose decision will be final except for a limited right of appeal under the Federal Arbitration Act. Any court with jurisdiction over the parties may enforce the arbitrator’s award.
YOU FURTHER AGREE THAT ANY PROCEEDINGS TO ARBITRATE OR LITIGATE ANY DISPUTE IN ANY FORUM WILL BE CONDUCTED SOLELY ON AN INDIVIDUAL BASIS. NEITHER YOU NOR VALNEVA WILL SEEK TO HAVE ANY DISPUTE HEARD AS A CLASS ACTION OR IN ANY OTHER PROCEEDING IN WHICH EITHER PARTY ACTS OR PROPOSES TO ACT IN A REPRESENTATIVE CAPACITY. No arbitration or other proceeding will be combined with another without the prior written consent of all parties to all affected arbitrations or proceedings.
Valneva and you agree that all disputes arising under these Terms of Use that cannot be settled through informal negotiation will be settled exclusively through confidential binding arbitration in accordance with the Consumer Arbitration Rules of the American Arbitration Association. The arbitrator’s award shall be binding and may be entered as a judgment in a court of competent jurisdiction. You agree that the Valneva may seek any interim or preliminary relief from a court of competent jurisdiction in New York necessary to protect its rights or property pending the completion of arbitration.
Any claims not subject to arbitration shall be subject to the exclusive jurisdiction of state or federal courts in New York, and you agree to submit to the personal and exclusive jurisdiction of such courts. Use of the Site constitutes consent to the application of those laws, as well as of the following terms and conditions.
9. Limitations of Liability
YOU EXPRESSLY UNDERSTAND AND AGREE THAT UNDER NO CIRCUMSTANCES WILL VALNEVA, ITS AFFILIATES AND ANY OF THEIR RESPECTIVE DIRECTORS, OFFICERS, EMPLOYEES, AGENTS, MANDATARIES OR OTHER REPRESENTATIVES BE LIABLE FOR DIRECT, INDIRECT, SPECIAL, INCIDENTAL, CONSEQUENTIAL, PUNITIVE OR AGGRAVATED DAMAGES, INCLUDING, WITHOUT LIMITATION, ANY LOSS OF USE, LOSS OF INCOME, SAVING OR PROFITS, LOSS OF DATA, LOSS OF GOODWILL, COST OF PROCUREMENT OF SUBSTITUTE SERVICES, OR ANY OTHER INDIRECT, SPECIAL, INCIDENTAL, OR CONSEQUENTIAL DAMAGES, HOWSOEVER CAUSED, AND ON ANY THEORY OF LIABILITY, WHETHER FOR BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE AND STRICT LIABILITY), OR OTHERWISE RESULTING FROM (1) THE USE OF, OR THE INABILITY TO USE, THE WEBSITE; (2) THE COST OF PROCUREMENT OF SUBSTITUTE SERVICES, ITEMS, OR WEBSITES; (3) UNAUTHORIZED ACCESS TO OR ALTERATION OF YOUR TRANSMISSIONS OR DATA (INCLUDING PERSONAL INFORMATION); (4) THE STATEMENTS OR CONDUCT OF ANY THIRD PARTY ON THE WEBSITE; OR (5) ANY OTHER MATTER RELATING TO THE WEBSITE. THESE LIMITATIONS WILL APPLY WHETHER OR NOT VALNEVA HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES AND NOTWITHSTANDING ANY FAILURE OF ESSENTIAL PURPOSE OF ANY LIMITED REMEDY. THIS EXCLUSION OF LIABILITY SHALL APPLY TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAWS. ANY CLAIM AGAINST US SHALL BE LIMITED TO THE AMOUNT YOU PAID, IF ANY, FOR THE USE OF THE SERVICES.
10. Modification or Suspension of the Site
We will make reasonable efforts to make the Site available but we may from time to time need to interrupt, restrict, modify or discontinue, temporarily or permanently the Site or parts of it without notice. We will not be responsible for any harm or loss you may suffer as a result of such actions.
11. Termination
We may at any time terminate your use of or access to the Site and may delete any or all of your User Content without prior notice if we have a good reason to do so which includes any breach by you of these Terms of Use and the Community Guidelines. We will not be responsible for any loss or harm you may suffer as a result of termination of your use of the Site in these circumstances.
12. Links to Third Party Sites
The Site may contain links or references to third party websites. These links are provided for your convenience only. No endorsement of any third party products, services or information is expressed or implied by any information, material or content of any third party contained in, referred to, included on, or linked from or to the Site. Any information, data, opinions, recommendations, products or services provided by such third parties through links to other websites or otherwise made available through their websites are solely those of such third parties and not of Valneva. Your use of such third party websites is subject to the terms of use and the privacy policies of such websites.
13. Indemnification
You agree to indemnify and hold harmless Valneva and its affiliates and their respective directors, officers, employees, agents, or other representatives from and against all claims, liability, damages and expenses, including without limitation all legal fees and costs arising from or relating to (a) your breach of these Terms of Use; (b) your use of the Site including without limitation transmission or placement of information or material by you on the Site; and (c) any claim or allegation that any of your User Content infringes the intellectual property or other proprietary rights, or privacy rights, of any third party.
14. Modifications to these Terms
We may make changes to the Terms of Use from time to time in our sole discretion, by updating these Terms of Use on the Site, and specifying the effective date of the new version of the Terms of Use. The “Last Modified” date at the top of these Terms of Use will indicate when the latest changes were made. Your continued use of the Site following the posting of a new version of the Terms of Use constitutes your acceptance of any such changes. Accordingly, whenever you visit the Site, you should check to see if a new version of the Agreement has been posted.
15. Contact Information
If you have any questions or concerns with respect to these Terms of Use or the Site you may contact us as identified in the Privacy Policy or the “Contact Us” section of the Site.
16. Severability
Should any part or provision of these Terms of Use be held unlawful, void, invalid, or unenforceable that portion shall be deemed severable from these Terms of Use and shall not affect the validity and enforceability of any remaining provisions.
17. Survival
All Sections shall survive the termination of the right to use the Site.
| Country | Affected areas | Transmission season | Comments |
|---|---|---|---|
| Australia | Outer Torres Strait Islands, northern Cape York | December–May; all human cases reported February–April | Rare cases reported from Outer Torres Strait Islands and 1 case previously reported from northern Queensland mainland Vaccine only recommended for Outer Torres Strait Islands |
| Bangladesh | Widespread | Year-round with most cases reported May–November | Cases reported from multiple areas, including Chittagong, Dhaka, Khulna, Rajshahi, Ranjpur, and Sylhet Divisions, so transmission likely countrywide |
| Bhutan | Presumed transmission in nonmountainous areas | Unknown | Rare cases reported but limited data Proximity to endemic areas of India and presence of vectors suggests transmission likely |
| Brunei Darussalam | Presumed widespread | Unknown | Limited data but outbreak reported in 2013 Proximity to Sarawak, Malaysia suggests ongoing transmission likely |
| Burma (Myanmar) | Presumed widespread | Year-round with most cases reported July–September | |
| Cambodia | Widespread | Year-round with peak season May–October | Cases reported from majority of provinces, so transmission likely countrywide |
| China | All provinces except Xinjiang and Qinghai | Peak season June–October | |
| India | Andhra Pradesh, Arunachal Pradesh, Assam, Bihar, Goa, Haryana, Jharkhand, Karnataka, Kerala, Maharashtra, Manipur, Meghalaya, Nagaland, Odisha, Punjab, Tamil Nadu, Telangana, Tripura, Uttar Pradesh, Uttarakhand, West Bengal | Peak season May–November, especially in northern India; the season may be extended or yearround in some areas, especially in southern India | |
| Indonesia | Widespread | Year-round, with peak season varying by island | Cases reported from many islands, including Sumatra, Java, Kalimantan, Bali, Nusa Tenggara, and Papua, so transmission likely on all islands Several traveler cases reported in recent years from Bali |
| Japan | All islands | June–October | Rare sporadic cases reported from all islands except Hokkaido Enzootic transmission without reported human cases on Hokkaido |
| Lao People’s Democratic Republic | Widespread | Year-round with peak season June–September | |
| Malaysia | Widespread | Year-round, with peak season in Sarawak from October–December | Much higher rates of disease reported from Sarawak than peninsular Malaysia |
| Nepal | Southern lowlands (Terai), some hill and mountain districts | Peak season June–October | Highest rates of disease reported from southern lowlands (Terai) Vaccine not routinely recommended for those trekking in high-altitude areas |
| North Korea | Presumed widespread | Unknown Proximity to South Korea suggests peak transmission May–November |
|
| Pakistan | Unknown | Unknown | Very limited data Rare cases reported from Sindh Province |
| Papua New Guinea | Widespread | Presumed year-round | Sporadic cases reported from Western Province, serologic evidence of disease from Gulf and Southern Highland Provinces, and 1 case reported from near Port Moresby, so transmission likely countrywide |
| Philippines | Widespread | Year-round with peak season April–August | Human, animal, and mosquito studies have indicated transmission in 32 provinces, so transmission likely on all islands |
| Russia | Primorsky Krai | June–September | Cases previously reported from Primorsky Krai Vaccine not routinely recommended |
| Singapore | Presumed in focal areas | Year-round | Very rare sporadic cases reported Vaccine not routinely recommended |
| South Korea | Widespread | May–November | |
| Sri Lanka | Widespread except in mountainous areas | Year-round with peak season November–February |
|
| Taiwan | Widespread | Peak season May–October | |
| Thailand | Widespread | Year-round with peak season May–October, especially in northern Thailand | Highest rates of disease reported from Chiang Mai Valley Several traveler cases reported in recent years from resort and coastal areas of southern Thailand |
| Timor-Leste | Presumed widespread | No data Proximity to West Timor suggests year-round |
|
| Viet Nam | Widespread | Year-round with peak season May–October, especially in northern Viet Nam |
*Destination and transmission season information should be considered in association with travel duration and activities when making decisions on vaccination.
†Data are based on published and unpublished reports. Risk assessments should be performed cautiously, because risk can vary within areas and from year to year, and surveillance data regarding human cases and JE virus transmission are often incomplete. In some endemic areas, human cases among residents are limited because of vaccination or natural immunity among older people. However, because JE virus is maintained in an enzootic cycle between animals and mosquitoes, susceptible visitors to these areas still may be at risk for infection.
‡Outbreaks previously occurred in the Western Pacific Islands of Guam (1947–1948) and Saipan (1990), but as they are no longer considered risk areas, they are not included in the table.
Last Updated: 01. May 2019
Valneva SE and its affiliates (“Valneva“,“we“, “us” or “our“) have created this privacy declaration (hereafter referred to as the “Privacy Declaration“) in order to demonstrate our firm commitment to privacy. The following discloses our processing of personal data (Article 4/1 Regulation (EU) 2016/679, “GDPR”) with regard to the use of our websites as well as with regard to our customers, pharmacovigilance, vendors and persons applying for a job at Valneva.
This Privacy Policy applies to individuals we deal with including consumers, patients, health care professionals and others within the health care or pharmaceutical industries (“you” or “your“), and explains how we collect, use, disclose and otherwise process and protect your Personal Data. This Privacy Policy further includes a description of your data privacy rights as a data subject.
1. Use of the Websites
With using our websites www.valneva.com, www.valneva.at, www.valneva.se, www.valnevauk.com, www.valneva.us, www.valneva.ca, www.preventje.com and the sub-sites under the listed domains you accept that we collect and process data regarding your behaviour on our website.
This processing is based on your consent being given by the usage of this website.
The Site may collect information from visitors both by asking you specific questions and by permitting you to communicate directly with us via email and/or feedback forms. Some of the information that you submit on the Site may be Personal Data. A site may further use “cookies” and Internet Protocol (“IP”) addresses. A cookie is a bit of information that a website sends to your web browser that helps the site remember information about you and your preferences and an IP address is a number assigned to your computer by your Internet service provider. The IP address can be used to diagnose problems with a server, report aggregate information, determine the fastest route for your computer to use in connecting to a site, and administer and improve the site. Please read more here: https://www.valneva.com/en/legal/cookie-policy
Please note that if you wish to subscribe and connect your personal social media account to our Site, e.g. if you would like to share information on your own social media account, certain Personal Data will be shared with us such as Personal Data linked to your profile or your friends profiles on the applicable social media account.
2. Pharmacovigilance
Pharmacovigilance is the process of discovering, evaluating, understanding and preventing adverse reactions or other problems related to medicines. Their notification is of great importance for public health. We will only use and share this information for pharmacovigilance purposes. This processing is necessary for compliance with a legal obligation to which Valneva is subject.
Valneva is required to store and report information relevant to pharmacovigilance to health authorities worldwide (including countries whose data protection levels differ from those of the EU). The reports contain detailed information on the incident, but only to a limited extent personal data.
With regard to patients, the notification will contain, if available, only age, date of birth, year of birth, gender and initials, depending on the information available, but never the name of the patient.
With regard to the notifier, the notification will include, depending on the information available, the name, professional activity (e.g. doctor, pharmacist), address, e-mail address and telephone number. The contact details are necessary to be able to follow up the reporting and thus obtain high-quality and complete information on adverse events.
Information on notifications will be kept for at least ten (10) years after the product is no longer on the market in any country.
3. Recruitment:
We will store and process your data for the purpose of your application based on your consent and based on Article 6/1 lit b General Data Protection Regulation. We will forward your personal data and the attachments you provided to the respective country organization with applicable open job opportunities. We will keep your personal data in evidence for filling additional positions for a maximum period of seven months from the date of the receipt of your application.
Your data will be kept strictly confidential, will not be passed on to any other companies except Valneva country organizations with applicable open job opportunities and will only be passed on within the company to the heads of departments where a suitable position is available.
Your data will be deleted automatically after seven (7) months from the date of receipt of your application. You can revoke your consent to data processing at any time in writing via gdpr@valneva.com. In this case please refer to your job application and we will delete your personal data.
4. Vendor, customer or other business partners:
We will not use your personal data for marketing activities unless you have consented to receive marketing communications from us.
Based either on consent or, when applicable, on the fulfilment of contractual obligations, we will store your name, contact details and your position within your company being a vendor, customer or other business partner.
Based on your consent, we will publish your data as a health care professional on our website www.reisemedizincheck.at (for Austria) or www.bewareofthebugs.com (for United Kingdom).
5. Medical Requests:
Your medical requests regarding our products will be stored due to legal obligations and in the legitimate interests of Valneva to have evidence about the information provided when replying to medical requests. We will store your name, contact details, content of your request and content of our reply to your request.
We will store this data for a period of 30 years after having received your medical request.
6. Security
We take reasonable steps to protect your Personal Data using physical (locked filing cabinets and restricted access to offices), electronic (especially firewalls) or procedural security measures appropriate to the sensitivity of the information. Valneva will take appropriate steps to ensure that Personal Data about you is protected from loss or theft, as well as unauthorised access, disclosure, copying, use or modification.
Although we have enacted security measures, we cannot guarantee the security of any information that you submit via email or over the Internet. To the extent permitted under applicable law, we make no warranty, express or implied, concerning the security or integrity of any Personal Data. You submit your Personal Data using such networks at your own risk, since no Internet transmission is ever 100% secure or error-free (in particular, emails sent to or from the Site may not be secure). You should take special care in deciding what information you send to us via email or posting on the Site. Moreover, where you use passwords, ID numbers or other special access features on the Site, it is your responsibility to safeguard them.
7. Links to other Websites
The Site may contain links or references to other websites to which this Privacy Policy does not apply. Valneva is not responsible for the data collection and use practices of companies or organisations to which the Site may provide links. We encourage you to read the privacy statement/policy of every website you visit.
Valneva makes no representations whatsoever about any other website which you may access through this Site. In addition, a link to a website does not mean that Valneva endorses or accepts any responsibility for the content, or the use, of such website
8. Collection of Personal Data from Children
This Site is not directed to individuals under the age of sixteen (16) (or such other lower age determined by applicable laws), and we do not knowingly collect any Personal Data from children under such age.
Should we need to process Personal Data of an individual under the age of sixteen (16) (or such other lower age determined by applicable laws) consent to such processing must be given by an authorized person with parental responsibility for the child.
9. Privacy Policy Changes
This Privacy Policy may be revised from time to time. If we intend to use or disclose Personal Data for purposes materially different than those described in this Privacy Policy, we will make reasonable efforts to notify affected individuals, if necessary, including by posting the revised Privacy Policy on this Site. We recommend that you review this Privacy Policy frequently.
10. Information Regarding Your Rights
If you would like to access your Personal Data or get it rectified, updated, erased or transferred to other organizations please contact us at the address below. You also have the right to object or to restrict some processing and, where we have asked for your consent to process your Personal Data, to withdraw your consent at any time and we will stop any future use of your Personal Data (unless there is a legitimate interest that prevents us from doing so). We may request a reasonable fee for administering certain requests. Authorised employees, agents and representatives of Valneva who require access to your Personal Data in order to fulfil their job requirements will have access to your Personal Data.
You may contact us by writing to us at the following address:
Valneva Austria GmbH, Campus Vienna Biocenter 3, A-1030 Vienna, Austria
You may also contact Valneva`s Data Protection Officer at:
NOTE: If you are a physician or other health care professional and would like to record an adverse event, please contact safety@valneva.com
11. Contact the Supervisory Authority
If you have any comments or complaints regarding the way your Personal Data is being handled, you have the right to contact the supervisory authority in your country of residence to lodge a complaint. Please click here to obtain relevant contact information to supervisory authorities: http://ec.europa.eu/justice/article-29/structure/data-protection-authorities/index_en.htm
I confirm that I am a US healthcare professional.
 |
 |
I confirm that I am a US resident.
|
|
I confirm that I am a US healthcare professional.
|
|
Do you or a member of your family work for the U.S. Department of Defense?
|
|
Do you or a member of your family work for the U.S. Department of Defense?
|
|
I am a Canadian healthcare professional.
|
|
I am a Canadian healthcare professional.
|
|
I am a Canadian resident.
|
|
I am a Canadian resident.
|
|
I confirm that I am a US resident.
|
|
Give IXIARO®
For travel in endemic areas:
ONE (1) MONTH
Consider
IXIARO®
For travel less than 1 month:
OUTDOORS:
OTHER PLANS:
OUTBREAKS:
Give IXIARO®
For travel in endemic areas:
ONE (1) MONTH
Consider
IXIARO®
For travel less than 1 month:
OUTDOORS:
OTHER PLANS:
OUTBREAKS:
| Country | Affected areas | Transmission season |
|---|---|---|
| Australia | Outer Torres Strait islands | December–May; all human cases reported February–April |
| Bangladesh | Presumed widespread | Most human cases reported May–October |
| Bhutan | Very rare reports; probably endemic in nonmountainous areas | No data |
| Brunei | Very rare reports; presumed to be endemic countrywide | Unknown; presumed year round |
| Burma (Myanmar) | Limited data; presumed to be endemic countrywide | Unknown; most human cases reported May–October |
| Cambodia | Presumed to be endemic countrywide | Year round; peak season May–October |
| China | Human cases reported from all provinces except Xizang (Tibet), Xinjiang and Qinghai. | Most human cases reported June–October |
| East Timor | Sporadic human cases reported; presumed to be endemic countrywide | No data; cases reported year round in neighboring West Timor |
| India | Human cases reported from all states except Dadra, Daman, Diu, Gujarat, Himachal Pradesh, Jammu and Kashmir, Lakshadweep, Meghalaya, Nagar Haveli, Punjab, Rajasthan and Sikkim | Most human cases reported May–October, especially in northern India; the season may be extended or year round in some areas, be extended or year round in some areas, especially in southern India |
| Indonesia | Presumed to be endemic countrywide | Year round; peak season varies by island |
| Japan** | Rare sporadic human cases on all islands except Hokkaido; enzootic activity ongoing | Most human cases reported July–October |
| Korea, North | Limited data; presumed to be endemic countrywide | No data; proximity to South Korea suggests peak transmission is likely to be May–October |
| Korea, South** | Rare sporadic human cases countrywide; enzootic activity ongoing | Most human cases reported May–October |
| Laos | Limited data; presumed to be endemic countrywide | Year round; peak season June–September |
| Malaysia | Endemic in Sarawak; sporadic cases reported from all other states; occasional outbreaks reported | Year round; in Sarawak, peak season October–December |
| Nepal | Endemic in southern Iowlands (Terai); cases also reported from hill and montain districts, including the Kathmandu valley | Most human cases reported June-October |
| Pakistan | Limited data; human cases reported from around Karachi | Unknown |
| Papua New Guinea | Limited data; probably widespread | Unknown; probably year round |
| Philippines | Limited data; presumed to be endemic on all islands | Year round; peak season June–September |
| Russia | Rare human cases reported from the Far Eastern maritime areas south of Khabarovsk | Most human cases reported July–September |
| Singapore | Rare sporadic human cases reported | Year round |
| Sri Lanka | Endemic countrywide except in mountainous areas | Year round; variable peaks based on monsoon rains |
| Taiwan** | Rare sporadic human cases islandwide | Most human cases reported May–October |
| Thailand | Endemic countrywide; seasonal epidemics in the northern provinces | Year round; peak season May–October, provinces especially in the north |
| Vietnam | Endemic countrywide; seasonal epidemics in the northern provinces | Year round; peak season May–October, especially in the north |
| Western Pacific Islands | Outbreaks of human disease reported in Guam in 1947–1948 and Saipan in 1990 | Unknown; most human cases reported October–March |
| *Data are based on published reports and personal correspondence. Risk assessments should be performed cautiously, because risk can vary within areas and from year to year, and surveillance data regarding human cases and JE virus transmission are incomplete. |
||
| **In some endemic areas, human cases among residents are limited because of natural immunity among older people or vaccination. However, because JE virus is maintained in an enzootic cycle between animalsand mosquitoes, susceptible visitors to these areas still may be at risk of infection. | ||
